Compare TDAY & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDAY | QURE |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | Netherlands |
| Employees | 7500 | 248 |
| Industry | Newspapers/Magazines | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.0M | 1.1B |
| IPO Year | N/A | 2013 |
| Metric | TDAY | QURE |
|---|---|---|
| Price | $7.30 | $16.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $9.00 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,107,000.00 |
| Revenue This Year | N/A | $126.12 |
| Revenue Next Year | N/A | $200.43 |
| P/E Ratio | $10.06 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.54 | $8.73 |
| 52 Week High | $7.50 | $71.50 |
| Indicator | TDAY | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 47.53 |
| Support Level | $6.58 | $13.47 |
| Resistance Level | $7.39 | $18.58 |
| Average True Range (ATR) | 0.24 | 1.33 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 74.46 | 59.22 |
USA Today Co Inc is a diversified media company with national and local reach, dedicated to empowering and enriching communities. It prioritizes a digital-first approach, focusing on audience growth and engagement while diversifying revenue streams. Through its trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including a network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, provide essential journalism, local content, and digital experiences to audiences and businesses. Its digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with digital marketing products and solutions.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.